Your browser doesn't support javascript.
loading
Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
Bliuc, D; Tran, T; van Geel, T; Adachi, J D; Berger, C; van den Bergh, J; Eisman, J A; Geusens, P; Goltzman, D; Hanley, D A; Josse, R G; Kaiser, S; Kovacs, C S; Langsetmo, L; Prior, J C; Nguyen, T V; Center, J R.
Afiliación
  • Bliuc D; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia. d.bliuc@garvan.org.au.
  • Tran T; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.
  • van Geel T; Maastricht University Medical Center, Research School CAPHRI, Care and Public Health Research Institute, Maastricht, The Netherlands.
  • Adachi JD; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Berger C; CaMos National Coordinating Centre, McGill University, Montreal, Quebec, Canada.
  • van den Bergh J; Research School Nutrim, Department of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Eisman JA; Department of Internal Medicine, VieCuri Medical Centre of Noord-Limburg, Venlo, The Netherlands.
  • Geusens P; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.
  • Goltzman D; School of Medicine Sydney, University of Notre Dame Australia, Sydney, Australia.
  • Hanley DA; Maastricht University Medical Center, Research School CAPHRI, Care and Public Health Research Institute, Maastricht, The Netherlands.
  • Josse RG; Biomedical Research Institute, University Hasselt, Hasselt, Belgium.
  • Kaiser S; Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Kovacs CS; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Langsetmo L; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Prior JC; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Nguyen TV; Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada.
  • Center JR; School of Public Health, University of Minnesota, Twin Cities, Minneapolis, MN, USA.
Osteoporos Int ; 30(4): 817-828, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30607457
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Difosfonatos / Conservadores de la Densidad Ósea / Fracturas Osteoporóticas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Difosfonatos / Conservadores de la Densidad Ósea / Fracturas Osteoporóticas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido